AGTR1 and Alzheimer disease: Kehoe et al. demonstrated that ACE-2 activity is reduced in AD, is an important regulator of the central classical ACE-1/Ang II/AT1R axis of RAS, and that dysregulation of this pathway likely plays a significant role in the pathogenesis of AD [11].